Novel drug combinations that improve survival outcomes, questions about treatment sequence, and encouraging results in chemo-resistant disease are highlights in ovarian cancer from ASCO 2025.

If you thought all personal trainers had rock-solid six-packs and zero health issues, you’d be wrong. Megan Johnson ...